|
|
|
|
|
TOKYO, Apr 24, 2018 - (JCN Newswire) - Showa Denko (SDK) has entered into an agreement with Astellas Pharma Inc. supporting its research on the practical applications of MucoRice-CTB, a rice-based oral vaccine, to be carried out with the Institute of Medical Science, the University of Tokyo, Chiba University and Asahi Kogyosha.
SDK will be responsible for providing Astellas with LED lighting and related equipment for plant growth, contributing to the development of MucoRice with know-how nourished through years of experience in plant factories.
Showa Denko's LED lighting systems for plant growth include LEDs that emit deep-red light with wavelengths of 660 nm, the optimal light for photosynthesis, with the highest levels of efficiency yet measured, and LEDs which emit blue light.
Using an S-method (SHIGYOTM Method) which irradiates deep-red and blue lights alternately in optimized cycles, the system creates an environment that allows a lettuce to grow to 150 grams only 30 days after seeding.
The system's equipment not only controls the lighting environment as desired, but applies to a variety of plant growth strategies as well. For more information, please visit www.sdk.co.jp/english/ or contact the SDK Public Relations Office at +81-3-5470-3235.
Topic: Press release summary
Source: Showa Denko K.K.
Sectors: Chemicals, Spec.Chem
http://www.acnnewswire.com
From the Asia Corporate News Network
Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
|
|
|
